These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20068287)

  • 1. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
    Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of α-klotho, fibroblast growth factor-, vitamin-D and calcium-sensing receptor in 70 patients with secondary hyperparathyroidism.
    Latus J; Lehmann R; Roesel M; Fritz P; Braun N; Ulmer C; Steurer W; Biegger D; Ott G; Dippon J; Alscher MD; Kimmel M
    Kidney Blood Press Res; 2013; 37(1):84-94. PubMed ID: 23552627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
    Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
    Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
    Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
    Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation.
    Hong YA; Choi DE; Lim SW; Yang CW; Chang YK
    Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased parathyroid expression of klotho in uremic rats.
    Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
    Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
    Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
    J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients.
    Krajisnik T; Olauson H; Mirza MA; Hellman P; Akerström G; Westin G; Larsson TE; Björklund P
    Kidney Int; 2010 Nov; 78(10):1024-32. PubMed ID: 20686451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
    Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
    Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
    Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB
    Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23 fails to inhibit uremic parathyroid glands.
    Canalejo R; Canalejo A; Martinez-Moreno JM; Rodriguez-Ortiz ME; Estepa JC; Mendoza FJ; Munoz-Castaneda JR; Shalhoub V; Almaden Y; Rodriguez M
    J Am Soc Nephrol; 2010 Jul; 21(7):1125-35. PubMed ID: 20431039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of parathyroid gland angiogenesis in chronic kidney disease associated with secondary hyperparathyroidism.
    Martins P; Schmitt F; Almeida H; Frazão JM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2889-94. PubMed ID: 18398016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
    Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
    Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating potential and apoptosis in the development of secondary hyperparathyroidism: a study based on Ki-67 immunohistochemical staining and the terminal dUTP nick-end labeling assay.
    Wada Y; Kunimura T; Sato S; Hisayuki T; Sato M; Imataka H; Yamashita N; Akizawa T; Moroboshi T
    Ther Apher Dial; 2008 Aug; 12(4):319-28. PubMed ID: 18789120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent alpha-Klotho (a-Kl) expression in the parathyroid glands of patients with secondary hyperparathyroidism.
    Ohkido I; Yokoyama K; Imura A; Utsunomiya Y; Hosoya T; Nabeshima Y
    Nephrol Dial Transplant; 2010 Mar; 25(3):1007-8; author reply 1008-9. PubMed ID: 20075437
    [No Abstract]   [Full Text] [Related]  

  • 17. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
    Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
    Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
    Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
    Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
    Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
    Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Klotho converts canonical FGF receptor into a specific receptor for FGF23.
    Urakawa I; Yamazaki Y; Shimada T; Iijima K; Hasegawa H; Okawa K; Fujita T; Fukumoto S; Yamashita T
    Nature; 2006 Dec; 444(7120):770-4. PubMed ID: 17086194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.